Feladilimab (Anti-ICOS/CD278 Reference Antibody (feladilimab), GSK3359609) is humanized IgG4 anti-ICOS agonist monoclonal antibody. Feladilimab binds to ICOS-expressing T cells. Feladilimab has the potential for the research of cancer[1].
Molecular Weight:
(145.52 kDa)
Purity:
99.255
CAS Number:
[2252518-85-5]
Target:
Transmembrane Glycoprotein
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted